Search PubMed⌕ Search

Biomedical subjects

J Yao

Publications and source records attributed to J Yao.

At least 55 records · Page 3Linked to original sources
PubMed2001

Conditional mutations in gamma-tubulin reveal its involvement in chromosome segregation and cytokinesis.

gamma-Tubulin is a conserved essential protein required for assembly and function of the mitotic spindle in humans and yeast. For example, human gamma-tubulin can replace the gamma-tubulin gene in Schizosaccharomyces pombe. To understand the structural/functional domains of gamma-tubulin, we performed a systematic alanine-scanning mutagenesis of human gamma-tubulin (TUBG1) and studied phenotypes of each mutant allele in S. pombe. Our screen, both in the presence and absence of the endogenous S. pombe gamma-tubulin, resulted in 11 lethal mutations and 12 cold-sensitive mutations. Based on structural mapping onto a homology model of human gamma-tubulin generated by free energy minimization, all deleterious mutations are found in residues predicted to be located on the surface, some in positions to interact with alpha- and/or beta-tubulins in the microtubule lattice. As expected, one class of tubg1 mutations has either an abnormal assembly or loss of the mitotic spindle. Surprisingly, a subset of mutants with abnormal spindles does not arrest in M phase but proceeds through anaphase followed by abnormal cytokinesis. These studies reveal that in addition to its previously appreciated role in spindle microtubule nucleation, gamma-tubulin is involved in the coordination of postmetaphase events, anaphase, and cytokinesis.

Amino Acid Sequence↗
PubMed2001

Bionic wavelet transform: a new time-frequency method based on an auditory model.

In this paper, a new adaptive wavelet transform, named bionic wavelet transform (BWT), is developed based on a model of the active auditory system. The most distinguishing characteristic of BWT is that its resolution in the time-frequency domain can be adaptively adjusted not only by the signal frequency but also by the signal instantaneous amplitude and its first-order differential. The automatically adjusted resolution, even in a fixed frequency along the time-axis, is achieved by introducing the active control of the auditory system into the wavelet transform (WT). Other properties of BWT include that: 1) BWT is a nonlinear transform that has high sensitivity and frequency selectivity; 2) BWT represents the signal with a concentrated energy distribution; and 3) the inverse BWT can reconstruct the original signal from its time-frequency representation. In order to compare these three properties between BWT and WT, experiments were conducted on both constructed signals and real speech signals. The results show that BWT performs better than WT in these three aspects, and that BWT is appropriate for speech signal processing, especially for cochlear implants.

Algorithms↗
PubMed2001

Parallel cascades: new ways to describe noise transfer in medical imaging systems.

A generalized approach to describing transfer of the noise power spectrum through medical imaging systems has been developed over the past several years in which image-forming processes are represented in terms of a cascade of amplified point processes. Until recently, this approach has been restricted to serial cascades only. Here we develop a generalized expression for the cross covariance of amplified point processes and an expression for the cross spectral density for wide-sense stationary conditions. These results extend the generalized transfer-theory approach to include the description of more complex image-forming processes involving parallel cascades of quantum amplification processes. This parallel-cascade approach is used to develop a theoretical expression for noise-power transfer in a simple radiographic screen that includes the effect of characteristic x-ray reabsorption. The result confirms earlier work by Metz and Vyborny, who showed that reabsorption increases image noise and decreases the detective quantum efficiency at low spatial frequencies. Use of the transfer-theory approach facilitates a straightforward generalization to many new digital imaging systems including conventional angiographic and active-matrix flat-panel systems.

Biophysical Phenomena↗
PubMed2001

The winged-helix protein brain factor 1 interacts with groucho and hes proteins to repress transcription.

Brain factor 1 (BF-1) is a winged-helix transcriptional repressor that plays important roles in both progenitor cell differentiation and regional patterning in the mammalian telencephalon. The aim of this study was to elucidate the molecular mechanisms underlying BF-1 functions. It is shown here that BF-1 interacts in vivo with global transcriptional corepressors of the Groucho family and also associates with the histone deacetylase 1 protein. The ability of BF-1 to mediate transcriptional repression is promoted by Groucho and inhibited by the histone deacetylase inhibitor trichostatin A, suggesting that BF-1 recruits Groucho and histone deacetylase activities to repress transcription. Our studies also provide the first demonstration that Groucho mediates a specific interaction between BF-1 and the basic helix-loop-helix protein Hes1 and that BF-1 potentiates transcriptional repression by Hes1 in a Groucho-dependent manner. These findings suggest that Groucho participates in the transcriptional functions of BF-1 by acting as both a corepressor and an adapter between BF-1 and Hes1. Taken together with the demonstration that these proteins are coexpressed in telencephalic neural progenitor cells, these results also suggest that complexes of BF-1, Groucho, and Hes factors may be involved in the regulation of progenitor cell differentiation in the telencephalon.

Amino Acid Sequence↗
PubMed2001

Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats.

In carbon tetrachloride-induced liver cirrhosis, diminution of hepatic endothelial nitric oxide synthase (eNOS) activity may contribute to impaired hepatic vasodilation and portal hypertension. The mechanisms responsible for these events remain unknown; however, a role for the NOS-associated proteins caveolin and calmodulin has been postulated. The purpose of this study is to characterize the expression and cellular localization of the NOS inhibitory protein caveolin-1 in normal rat liver and to then examine the role of caveolin in conjunction with calmodulin in regulation of NOS activity in cholestatic portal hypertension. In normal liver, caveolin protein is expressed preferentially in nonparenchymal cells compared with hepatocytes as assessed by Western blot analysis of isolated cell preparations. Additionally, within the nonparenchymal cell populations, caveolin expression is detected within both liver endothelial cells and hepatic stellate cells. Next, studies were performed 4 wk after bile duct ligation (BDL), a model of portal hypertension characterized by prominent cholestasis, as evidenced by a significant increase in serum cholesterol in BDL animals. After BDL, caveolin protein levels from detergent-soluble liver lysates are significantly increased as assessed by Western blot analysis. Immunoperoxidase staining demonstrates that this increase is most prominent within sinusoids and venules. Additionally, caveolin-1 upregulation is associated with a significant reduction in NOS catalytic activity in BDL liver lysates, an event that is corrected with provision of excess calmodulin, a protein that competitively binds eNOS from caveolin. We conclude that, in cholestatic portal hypertension, caveolin may negatively regulate NOS activity in a manner that is reversible by excess calmodulin.

Animals↗
PubMed2001

Central angiotensin induction of fetal brain c-fos expression and swallowing activity.

The present study examined physiological and cellular responses to central application of ANG II in ovine fetuses and determined the fetal central ANG-mediated dipsogenic sites in utero. Chronically prepared near-term ovine fetuses (130 +/- 2 days) received injection of ANG II (1.5 microg/kg icv). Fetuses were monitored for 3.5 h for swallowing activity, after which animals were killed and fetal brains were perfused for subsequent Fos staining. Intracerebroventricular ANG II significantly increased fetal swallowing in near-term ovine fetuses (1.1 +/- 0.2 to 4.5 +/- 1.0 swallows/min). The initiation of stimulated fetal swallowing activity was similar to the latency of thirst responses (drinking behavior) elicited by central ANG II in adult animals. ANG II evoked increased Fos staining in putative dipsogenic centers, including the subfornical organ, organum vasculosum of the lamina terminalis, and median preoptic nucleus. Intracerebroventricular injection of ANG II also caused c-fos expression in the fetal hindbrain. These results indicate that an ANG II-mediated central dipsogenic mechanism is intact before birth, acting at sites consistent with the dipsogenic neural network. Central ANG II mechanisms likely contribute to fetal body fluid and amniotic fluid regulation.

Angiotensin II↗
PubMed2001

Endothelin is a potent inhibitor of matrix metalloproteinase-2 secretion and activation in rat mesangial cells.

We examined the effects of endothelin (ET) on the activity of matrix metalloproteinase-2 (MMP-2) in cultured MCs. Addition of the ET(A) receptor antagonists or neutralizing anti-endothelin antibody into MC cultures markedly augmented the secretion and activation of MMP-2. On the contrary, addition of the exogenous ET-1 into MC culture significantly inhibited the synthesis of MMP-2 in both basal and cytokines (tumor necrosis factor-alpha and interferon-gamma) plus lipopolysaccharide-stimulated conditions. Furthermore, pretreatment of cells with exogenous ET-1 obviously prevented cytochalasin D-elicited activation of MMP-2, an effect that was completely abolished by ET(A) receptor antagonist, FR139317. In addition, ET-1 was found to be able to suppress the expression of membrane type-1 MMP (MT1-MMP) and promote the conversion of tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) from cell associated form to secreted form. The addition of recombinant TIMP-2 into the culture abrogated dose-dependently the cytochalasin D-elicited activation of MMP-2. These results suggest that ET is a potent inhibitor of MMP-2 secretion and activation in MCs. These novel findings may help us understand the subtle regulation of the synthesis and activation of MMP-2 in MCs. It also provides us with further insight into the pathophysiological mechanisms involving ET in the regulation of matrix turnover in glomerulus.

Animals↗
PubMed2001

Goosecoid promotes head organizer activity by direct repression of Xwnt8 in Spemann's organizer.

Formation of the vertebrate body plan is controlled by discrete head and trunk organizers that establish the anteroposterior pattern of the body axis. The Goosecoid (Gsc) homeodomain protein is expressed in all vertebrate organizers and has been implicated in the activity of Spemann's organizer in Xenopus. The role of Gsc in organizer function was examined by fusing defined transcriptional regulatory domains to the Gsc homeodomain. Like native Gsc, ventral injection of an Engrailed repressor fusion (Eng-Gsc) induced a partial axis, while a VP16 activator fusion (VP16-Gsc) did not, indicating that Gsc functions as a transcriptional repressor in axis induction. Dorsal injection of VP16-Gsc resulted in loss of head structures anterior to the hindbrain, while axial structures were unaffected, suggesting a requirement for Gsc function in head formation. The anterior truncation caused by VP16-Gsc was fully rescued by Frzb, a secreted Wnt inhibitor, indicating that activation of ectopic Wnt signaling was responsible, at least in part, for the anterior defects. Supporting this idea, Xwnt8 expression was activated by VP16-Gsc in animal explants and the dorsal marginal zone, and repressed by Gsc in Activin-treated animal explants and the ventral marginal zone. Furthermore, expression of Gsc throughout the marginal zone inhibited trunk formation, identical to the effects of Frzb and other Xwnt8 inhibitors. A region of the Xwnt8 promoter containing four consensus homeodomain-binding sites was identified and this region mediated repression by Gsc and activation by VP16-Gsc, consistent with direct transcriptional regulation of Xwnt8 by Gsc. Therefore, Gsc promotes head organizer activity by direct repression of Xwnt8 in Spemann's organizer and this activity is essential for anterior development.

Animals↗
PubMed2001

Detection of viable myocardium by transvenous myocardial contrast echocardiography using harmonic power Doppler: canine model of acute coronary occlusion and reperfusion.

STUDY OBJECTIVE: To assess whether myocardial contrast echocardiography (MCE) using harmonic power Doppler (HPD) in conjunction with the transvenous contrast agent SHU 563A would be useful in detecting stunned but viable myocardium. DESIGN: Acute coronary occlusion (2 to 3 h) followed by 1 h of reperfusion was created in 10 dogs in an open-chest model. MEASUREMENTS AND RESULTS: Continuous harmonic B-mode for wall motion analysis and ECG triggered HPD for assessment of myocardial perfusion was employed during coronary occlusion and after reperfusion. Postmortem 2,3,5-triphenyltetrazolium chloride (TTC) staining was performed to verify infarction. Extent of wall motion abnormality (WMA), perfusion defect size, and anatomic infarct size (myocardial infarction [MI]) were analyzed in a 5-segment model. All 10 dogs showed WMA in 23 of 50 segments during coronary occlusion. In eight dogs, HPD detected perfusion defects in 18 of 50 segments. The concordance rate between WMA and perfusion defect was 86%. Mean linearized power (MLP) in segments with WMA was significantly lower compared to normal segments (60.7 +/- 38.9 vs 110.5 +/- 108.8, p < 0.05). After reperfusion, the extent of WMA was larger than the area of perfusion defect (percentage of left ventricular slice area): 30 +/- 13% vs 9 +/- 8%, p < 0.01. Eventual infarct size was 6 +/- 7%. WMAs were seen in 18 of 50 segments. TTC confirmed MI in 7 of 18 segments. MLP in segments with WMA but no MI was significantly higher compared to segments with WMA and MI (84.5 +/- 67.3 vs 13.2 +/- 9.6, p < 0.01). Thus, the extent of WMA after reperfusion was greater than the size of perfusion defect and eventual MI, indicating the presence of stunned but viable myocardium. CONCLUSION: MCE using HPD and the contrast agent SHU 563A can demonstrate the efficacy of reperfusion, identify necrotic regions, and aid in the recognition of stunned but viable myocardium. This approach could be useful clinically in patients with acute MI undergoing reperfusion therapy.

Animals↗
PubMed2001

Reconstructing hierarchical tetrahedral mesh density models of bony anatomy.

We proposed an efficient and automatic method to reconstruct hierarchical tetrahedral meshes and build density models for bony anatomy from CT data sets. The mesh is reconstructed from contours extracted in CT images corresponding to the outer bone surfaces and the boundaries between compact bone, spongy bone and medullary cavity. Key problems, such as tiling problem, branching problem, correspondence problem, and constraint problem, have been solved. We then approximated bone density variations by means of continuous density functions in each tetrahedron. The density functions are written as smooth Bernstein polynomial spline expressed in terms of barycentric coordinates associated with each tetrahedron. We further performed the tetrahedral mesh simplification by edge collapsing and built hierarchical structure of multiple resolution meshes. We applied our density model to efficiently generate Digitally Reconstructed Radiographs. This research is part of our effort to build a bone density atlas.

Algorithms↗
PubMed2001

[Diagnostic value of five serum markers for liver fibrosis].

OBJECTIVE: To research the diagnostic value of serum hyaluronic acid (HA), type III procollagen (PCIII), type IV collagen (CIV), laminin (LN), and transforming growth factor-beta(1) (TGF-beta(1)) for liver fibrosis in patients with chronic hepatitis. METHODS: Serum levels of HA, PCIII, CIV, LN and TGF-beta(1) in 116 patients with chronic hepatitis and cirrhosis were investigated and compared with hepatic histological findings of 87 patients. RESULTS: The correlation between serum HA and histologically assessed grade of inflammatory activity was weak (r=0.393, P<0.05). The correlation between serum HA, PCIII, LN, TGF-beta(1) and histologically assessed stage of liver fibrosis were all moderate (r=0.584, 0.454, 0.441 and 0.612, respectively, P<0.05), while that between serum CIV and histologically assessed stage of liver fibrosis was weak (r=0.319, P<0.05). As shown by the ROC curves in cases of chronic hepatitis, the ability to differentiate patients with cirrhosis from those without cirrhosis was greater for serum HA than that for serum PCIII, CIV, LN, and TGF-beta(1) (the areas under the curves=0.904 vs 0.784, 0.815, 0.805, 0.828, P<0.05). The ability of serum HA, LN and TGF-beta(1) to differentiate patients with extensive liver fibrosis from those with no or mild liver fibrosis exceeded that of serum PCIII and CIV (the areas under the curves=0.849, 0.819, 0.836 vs 0.702, 0.721, P<0.05). To discriminate the stage of liver fibrosis, serum HA and TGF-beta(1) were selected from the five markers by Bayes discriminate analysis. If S(1), S(2) and S(3) were not required to be discriminated, discrimination between the three stages showed significant difference (P<0.05). The predictive accurate percentage was 72.90%. CONCLUSIONS: The five markers all have the ability not only to judge liver cirrhosis, in which the ability of serum HA is the best, but also to differentiate chronic hepatitis with extensive liver fibrosis from that with no or mild liver fibrosis, in which the ability of serum HA, LN, TGF-beta(1) is stronger than the other two. It is useful for detection of serum HA and TGF-beta(1) at the same time to discriminate the histologically assessed stage of fibrosis. Serum HA and TGF-beta(1) can be helpful in discriminating patients of chronic hepatitis with "no liver fibrosis", "liver fibrosis but no cirrhosis" and "liver cirrhosis", but cannot discriminate them accurately as the histologically assessed stage of fibrosis. They cannot displace liver biopsy for the judgement of liver fibrosis.

Adult↗
PubMed2001

[Construction and expression in eukaryotic cells of HBsAg and B].

OBJECTIVE: To investigate the enhanced role of B(7-1) in gene immunization of eukaryotic vector expressing HBsAg, and further to eliminate the immunotolerance to hepatitis B virus. METHODS: B(7-1) and IRES-HBs with linker and promoter sequence prior to HBs gene were amplified with high fidelity PCR, then subcloned into plasmid pBluescriptks+, which was used to sequence. The eukaryotic expressing vector was constructed by inserting B(7-1) and IRES-HBs into plxsn. Recombinant vector was transfected into PA317 by means of lipid mixtures. Titre of pseudovirus packaged in PA317 cells was detected by infecting NIH3T3 cells. B(7-1) and HBsAg expression in PA317, NIH3T3, HepG(2), 293, EL4 cell lines was detected by RT-PCR, immunohistochemistry and ELISA, respectively. RESULTS: No change was found in the sequences of target genes amplified by high fidelity PCR compared with the known sequences. Plxsn-B(7-1)-HBs was constructed by first inserting B(7-1) into plxsn with enzyme EcoRI/XhoI, then IRES-HBs was inserted in the same way with enzyme XhoI/BamHI. 43 and 90 G418-resistant clones were obtained two weeks later after 1:10 and 1:5 passages at 24 hours after transfection. Titre of the peudovirus was 5.4x10(5) CFU/ml. B(7-1) was expressed in all the cell lines above by RT-PCR test. The contents of HBsAg in the supernatant of the PA317, NIH3T3, HepG(2), and 293 cells at 24, 48, 72 hours intervals were 0.15, 0.11, 0.20, 0.13; 0.63, 0.47, 0.76, 0.58; 0.77, 0.61, 0.89, 0.69, respectively. CONCLUSIONS: The retroviral vector expressing B(7-1) and HBsAg simultaneously is constructed successfully. The target antigens are expressed in above cell lines in vitro after transfection with lipids mixtures. It may be used to conduct gene immunization and to investigate the role of B(7-1) on HBsAg immune response, which may be further used to the prevention and therapy of hepatitis B.

Animals↗
PubMed2001

[Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].

OBJECTIVE: To evaluate the anti-fibrotic effect of interferon alpha and to study the relationship between the anti-fibrotic effect and the efficacy of anti-virus in patients with chronic hepatitis B treated with interferon alpha. METHODS: Thirty-six patients with chronic hepatitis B were treated with interferon alpha. Before, during and after the treatment, the levels of hyaluronic acid (HA), type III procollagen (PC-III), type IV collagen(IV-C), laminin (LN) and transforming growth factor beta 1 (TGF-beta 1) were measured as the markers of hepatic fibrosis. Needle biopsy sections of the liver taken before and at the end of IFN treatment were assessed and compared according to the modified histological activity index (HAI) and hepatic fibrosis (HF) scoring system. RESULTS: In IFN group, the levels of HA, PC-III, IV-C, LN, and TGF-beta 1 after treatment were all significantly lower than those before treatment (P<0.01). The levels of HA, PC-III, and TGF-beta 1 after treatment were significantly lower in IFN group than in control one. HAI scores decreased from 9.3+/-3.2 to 6.2 +/-2.1 and HF scores decreased from 7.5+/-2.2 to 5.1+/-1.8 after treatment. CONCLUSIONS: The improvement of hepatic fibrosis closely related to the efficacy of anti-virus. Interferon alpha therapy is effective for hepatic fibrosis of chronic hepatitis B.

Adolescent↗
PubMed2001

Lowering of sodium deoxycholate-induced nasal ciliotoxicity with cyclodextrins.

AIM: To lower the nasal ciliotoxicity of sodium deoxycholate (SDC) in combination with cyclodextrins (CD). METHODS: The erythrocyte hemolysis test was carried out to evaluate the damaging effect of SDC on the erythrocyte membrane. The in situ toad palate model and scanning electron microscope technique were used to investigate the nasal ciliotoxicity of SDC solution in combination with CD. The inclusion effect between SDC and beta-cyclodextrin (beta-CD) was studied by differential thermal analysis (DTA) and X-ray diffractometry. RESULTS: The hemolysis test showed that beta-CD and dimethyl-beta-cyclodextrin (DM-beta-CD) could effectively protect the erythrocyte membrane against damage by SDC at the molar ratios of 1:1 and 2:1. When SDC combined with beta-CD or DM-beta-CD at a molar ratio of 1:2 or 1:3, the ciliotoxicity of SDC was greatly alleviated and the percent lasting time of the ciliary movement increased to 50 % or above. Scanning electron microscope investigations showed that SDC combined with beta-CD at a molar ratio 1:2 had no marked damage on the rat nasal mucosa after nasal administration thrice a day for a week. DTA and X-ray diffractometry investigations showed that SDC formed an inclusion with beta-CD. CONCLUSION: Combining beta-CD or DM-beta-CD with SDC can greatly lower the hemolytic effect and ciliotoxicity of SDC and the optimal molar ratio of SDC to CD is 1:2. Such protection provided by CD is due to the inclusion effect between SDC and CD.

Absorption↗
PubMed2001

Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.

AIM: To evaluate the nasal absorption enhancement of insulin by sodium deoxycholate (SDC) in combination with cyclodextrins (CD). METHODS: The concentration of glucose in blood was measured. Scanning electron microscopy technique was used to investigate the effect of enhancers on the nasal mucocilia. The effect of SDC in combination with CD on the leucine aminopeptidase (LAP) activity in the nasal mucosa was observed. RESULTS: Intranasal administration of insulin (4 U/kg) along with 0.75 % SDC/beta-CD at a molar ratio of 1 : 2 slowly decreased the blood glucose levels of rats. The minimal blood glucose level was (72.6 +/- 2.1) % of baseline, and which was lasted for 3 h. Though the decrement of blood glucose in 0.75 % SDC/beta-CD (1 : 2) treated group was less than that in 0.75 % SDC treated group, there was no significant difference between the two groups in AOC0- t values (P > 0.05). SDC (0.01 %) solution did not have any absorption prompting effect. Scanning electron microscopy investigation showed that 0.75 % SDC/beta-CD (1 : 2) solution had no marked damage on rat nasal mucosa 4 h after nasal administration, while 0.01 % SDC still had some damage on the rat nasal mucosa. The inhibitory effect of SDC on the LAP activity was decreased from 89.2 % to 69.2 %, 71.5 %, 60.4 %, and 61.3 % in 0.75 % SDC/beta-CD (1 : 1), 0.75 % SDC/beta-CD (1 : 2), 0.75 % SDC/DM-beta-CD (1 : 1), and 0.75 % SDC/DM-beta-CD (1 : 2) treated group, respectively. CONCLUSION: Combining beta-CD with SDC lowered the serious nasal ciliotoxicity of SDC and had a marked absorption promoting effect, which was not due to low concentration of SDC but was related with the inhibition of LAP activity.

Absorption↗
PubMed2001

[Accurate diagnosis of stages of hepatic fibrosis by measuring levels of serum hyaluronic acid, procollagen type III, and collagen type IV].

OBJECTIVE: To study the accurate diagnosis of various stages of hepatic fibrosis by measuring serum hyaluronic acid (HA), procollagen type III (PC III), and collagen type IV (CIV). METHODS: The concentrations of serum HA, PC III, CIV in 253 patients with chronic liver disease were measured by radioimmunoassay. Liver biopsies were performed in all of the patients at the same time. According to the results of liver pathological diagnosis, we assessed the ability of serum HA, PC III and CIV to identify correctly patients with hepatic fibrosis (staging >or=S(2)) or cirrhosis (S(4)). RESULTS: The cutoff value of HA, PC III and C IV to identify correctly patients with hepatic fibrosis was 90 microg/L, 90 microg/L, 75 microg/L respectively. The sensitivity (Se) was 80.4%, 82%, 63.1%; the specificity (Spe) was 70.2%, 60.8%, 83.8%; the positive prediction value (PPV) was 86.7%, 83.5%, 90.4%; the negative prediction value (NPV) was 59.8%, 58.4%, 48.4%, respectively. The cutoff value to identify patients with cirrhosis was: HA 210 microg/L, Se 96.2%, Spe 85.3%, PPV 65.4%, NPV 98.8%; PC III 150 microg/L, Se 76.4%, Spe 68.7%, PPV 40.4%, NPV 91.3%; C IV 90 microg/L, Se 80%, Spe 75.8%, PPV 47.8%, NPV 93.2%, respectively. CONCLUSIONS: The determination of serum HA, PC III and C IV can make relatively accurate diagnosis to various stages of hepatic fibrosis. HA is the best for diagnosis of liver cirrhosis.

Biopsy↗
PubMed2001

[Pathological changes between HBeAg and anti-HBe in patients with chronic hepatitis B].

OBJECTIVE: To observe the differences of pathological changes between HBeAg and anti-HBe in chronic hepatitis B. METHODS: Liver biopsy was performed in patients with chronic hepatitis B. The histopathological grading and staging were carried out. Serum markers of viral hepatitis were tested. RESULTS: (1) The histopathological grading and staging were closely correlated with the appearance of serum HBeAg and anti-HBe. The number of G(3-4) and S(3-4) in anti-HBe cases was significantly higher than that of G(1-2) and S(1-2), respectively. The number of G(1-2) and S(1-2) in HBeAg cases was significantly higher than that of G(3-4) and S(3-4), respectively. Significant differences were found between the group of anti-HBe cases and the group of HBeAg cases (P<0.005). (2) HBV DNA was detected in 126 of 151 HBeAg positive patients (83.4%), and the positive rate of HBV DNA in anti-HBe positive patient was 29% only. CONCLUSIONS: (1) Severe inflammatory, necrosis and fibrosis of hepatic tissue are observed in patients with anti-HBe positive chronic hepatitis B. (2) Although HBV DNA is positively correlated to HBeAg, HBV-DNA can be detected in part of anti-HBe positive patients.

Biomarkers↗